Finasteride for Chronic Central Serous Chorioretinopathy
NCT01585441
·
clinicaltrials.gov ↗
PHASE2
Phase
TERMINATED
Status
6
Enrollment
NIH
Sponsor class
Stopped
This study was terminated early due to lack of enrollment.
Conditions
Retinal Disease
Interventions
DRUG:
Finasteride
DRUG:
Placebo
Sponsor
National Eye Institute (NEI)
Collaborators
[object Object]